4.6 Article

A Novel Nodule Edge Sharpness Radiomic Biomarker Improves Performance of Lung-RADS for Distinguishing Adenocarcinomas from Granulomas on Non-Contrast CT Scans

期刊

CANCERS
卷 13, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/cancers13112781

关键词

lung nodule classification; CT images; lung-RADS; nodule interface sharpness; nodule risk score

类别

资金

  1. National Cancer Institute [1U24CA199374-01, R01CA249992-01A1, R01CA202752-01A1, R01CA208236-01A1, R01CA216579-01A1, R01CA220581-01A1, R01CA257612-01A1, 1U01CA239055-01, 1U01CA24822601, 1U54CA254566-01]
  2. National Heart, Lung and Blood Institute [1R01HL15127701A1]
  3. National Institute of Biomedical Imaging and Bioengineering [1R43EB028736-01]
  4. National Center for Research Resources [1 C06 RR12463-01]
  5. VA Merit Review Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service the Office of the Assistant Secretary of Defense for Health Affairs [IBX004121A, W81XWH-19-1-0668, W81XWH-15-1-0558, W81XWH-20-1-0851]
  6. Lung Cancer Research Program [W81XWH-18-1-0440, W81XWH-20-10595]
  7. Peer Reviewed Cancer Research Program [W81XWH-18-1-0404]
  8. Kidney Precision Medicine Project (KPMP) Glue Grant the Ohio Third Frontier Technology Validation Fund
  9. Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health [UL1TR0002548]
  10. NIH roadmap for Medical Research
  11. Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University

向作者/读者索取更多资源

The new radiomic feature NIS can help distinguish lung adenocarcinomas from benign granulomas on non-contrast CT scans and potentially improve the performance of Lung-RADS. By reclassifying initially suspicious benign nodules, NIS has the potential to significantly reduce unnecessary biopsies and follow-up imaging.
Simple Summary The great majority of pulmonary nodules on screening CT scans are benign (95%). Due to inaccurate diagnoses of granulomas from adenocarcinomas on CT scans, many patients with benign nodules are subjected to unnecessary surgical procedures. The aim of this retrospective study is to evaluate the discriminability of a new radiomic feature, nodule edge/interface sharpness (NIS), for distinguishing lung adenocarcinomas from benign granulomas on non-contrast CT scans. Moreover, we aim to evaluate whether NIS can improve the performance of Lung-RADS, by reclassifying benign nodules that were initially assessed as suspicious. In a cohort of 352 patients with diagnostic non-contrast CT scans, NIS radiomics was able to classify nodules with an area under the receiver operating characteristic curve (ROC AUC) of 0.77, and when combined with intra-tumoral textural and shape features, classification performance increased to AUC of 0.84. Additionally, the NIS classifier correctly reclassified 46% of those lesions that were actually benign but deemed suspicious by Lung-RADS. Combining NIS with Lung-RADS has the potential to alter patient management by significantly decreasing unnecessary biopsies/follow up imaging. The aim of this study is to evaluate whether NIS radiomics can distinguish lung adenocarcinomas from granulomas on non-contrast CT scans, and also to improve the performance of Lung-RADS by reclassifying benign nodules that were initially assessed as suspicious. The screening or standard diagnostic non-contrast CT scans of 362 patients was divided into training (S-t, N = 145), validation (S-v, N = 145), and independent validation (S-iv, N = 62) sets from different institutions. Nodules were identified and manually segmented on CT images by a radiologist. A series of 264 features relating to the edge sharpness transition from the inside to the outside of the nodule were extracted. The top 10 features were used to train a linear discriminant analysis (LDA) machine learning classifier on St. In conjunction with the LDA classifier, NIS radiomics classified nodules with an AUC of 0.82 +/- 0.04, 0.77, and 0.71 respectively on S-t, S-v, and S-iv. We evaluated the ability of the NIS classifier to determine the proportion of the patients in S-v that were identified initially as suspicious by Lung-RADS but were reclassified as benign by applying the NIS scores. The NIS classifier was able to correctly reclassify 46% of those lesions that were actually benign but deemed suspicious by Lung-RADS alone on S-v.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据